Skip to main content
. 2020 May 11;11(5):349. doi: 10.1038/s41419-020-2542-9

Fig. 3. Cellular effect and ways of MSCs therapy in cardiovascular disease through inflammatory regelation.

Fig. 3

Mo, monocyte; Ma, macrophage; M1; subtype I of macrophage; M2; subtype II of macrophage; T, T cells; Treg, regulatory T cell; NK, natural killer cell; MCP-1, monocyte chemoattractant protein-1; IgG, immunoglobulin G; IgM, immunoglobulin M; NKp30, natural killer cell protein 30.